Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype

Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype / Doldi, V., Tortoreto, M., Colecchia, M., Maffezzini, M., Percio, S., Giammello, F., Brandalise, F., Gandellini, P., Zaffaroni, N.. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 43:1(2024), p. 161. [10.1186/s13046-024-03081-0]